Ultralife Corp (NASDAQ: ULBI) has seen a decline in its stock price by -4.05 in relation to its previous close of 11.37. However, the company has experienced a -2.15% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2024-07-25 that Ultralife Corporation (NASDAQ:ULBI ) Q2 2024 Results Conference Call July 25, 2024 8:30 AM ET Company Participants Jody Burfening – IR Mike Manna – President and CEO Phil Fain – CFO Conference Call Participants Josh Sullivan – The Benchmark Company Operator Good day, and thank you for standing by. Welcome to Ultralife Corporation Second Quarter 2024 Results Conference Call.
Is It Worth Investing in Ultralife Corp (NASDAQ: ULBI) Right Now?
Ultralife Corp (NASDAQ: ULBI) has a price-to-earnings ratio of 17.11x that is above its average ratio. Additionally, the 36-month beta value for ULBI is 0.98. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ULBI is 10.12M and currently, short sellers hold a 2.76% ratio of that float. The average trading volume of ULBI on July 26, 2024 was 126.57K shares.
ULBI’s Market Performance
The stock of Ultralife Corp (ULBI) has seen a -2.15% decrease in the past week, with a 15.08% rise in the past month, and a 24.97% gain in the past quarter. The volatility ratio for the week is 6.74%, and the volatility levels for the past 30 days are at 5.92% for ULBI. The simple moving average for the last 20 days is -0.16% for ULBI stock, with a simple moving average of 19.28% for the last 200 days.
Analysts’ Opinion of ULBI
Many brokerage firms have already submitted their reports for ULBI stocks, with The Benchmark Company repeating the rating for ULBI by listing it as a “Buy.” The predicted price for ULBI in the upcoming period, according to The Benchmark Company is $12 based on the research report published on March 26, 2021 of the previous year 2021.
Ardour Capital gave a rating of “Hold” to ULBI, setting the target price at $4.50 in the report published on November 04th of the previous year.
ULBI Trading at -0.65% from the 50-Day Moving Average
After a stumble in the market that brought ULBI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.52% of loss for the given period.
Volatility was left at 5.92%, however, over the last 30 days, the volatility rate increased by 6.74%, as shares surge +5.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.52% lower at present.
During the last 5 trading sessions, ULBI fell by -2.15%, which changed the moving average for the period of 200-days by +10.99% in comparison to the 20-day moving average, which settled at $10.96. In addition, Ultralife Corp saw 59.97% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ULBI starting from Goddard Janie, who purchase 1,397 shares at the price of $10.91 back on Jun 07 ’24. After this action, Goddard Janie now owns 4,381 shares of Ultralife Corp, valued at $15,241 using the latest closing price.
Manna Michael Edward, the President and CEO of Ultralife Corp, purchase 1,000 shares at $8.60 during a trade that took place back on Mar 13 ’24, which means that Manna Michael Edward is holding 18,374 shares at $8,600 based on the most recent closing price.
Stock Fundamentals for ULBI
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.26 for the gross margin
The net margin for Ultralife Corp stands at 0.06. The total capital return value is set at 0.09. Equity return is now at value 8.51, with 5.93 for asset returns.
Based on Ultralife Corp (ULBI), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is 10.98.
Currently, EBITDA for the company is 13.39 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 1.1. The receivables turnover for the company is 5.44for trailing twelve months and the total asset turnover is 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.03.
Conclusion
In conclusion, Ultralife Corp (ULBI) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
